CA1299577C - Acides tetrahydrocarbazole-1-alcanoiques - Google Patents

Acides tetrahydrocarbazole-1-alcanoiques

Info

Publication number
CA1299577C
CA1299577C CA000527083A CA527083A CA1299577C CA 1299577 C CA1299577 C CA 1299577C CA 000527083 A CA000527083 A CA 000527083A CA 527083 A CA527083 A CA 527083A CA 1299577 C CA1299577 C CA 1299577C
Authority
CA
Canada
Prior art keywords
chlorobenzyl
acetic acid
alkyl
phenyl
tetrahydro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA000527083A
Other languages
English (en)
Inventor
John W. Gillard
Yvan Guindon
Christiane Yoakim
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Frosst Canada and Co
Original Assignee
Merck Frosst Canada and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Frosst Canada and Co filed Critical Merck Frosst Canada and Co
Priority to CA000527083A priority Critical patent/CA1299577C/fr
Application granted granted Critical
Publication of CA1299577C publication Critical patent/CA1299577C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/82—Carbazoles; Hydrogenated carbazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA000527083A 1987-01-09 1987-01-09 Acides tetrahydrocarbazole-1-alcanoiques Expired - Lifetime CA1299577C (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA000527083A CA1299577C (fr) 1987-01-09 1987-01-09 Acides tetrahydrocarbazole-1-alcanoiques

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA000527083A CA1299577C (fr) 1987-01-09 1987-01-09 Acides tetrahydrocarbazole-1-alcanoiques

Publications (1)

Publication Number Publication Date
CA1299577C true CA1299577C (fr) 1992-04-28

Family

ID=4134725

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000527083A Expired - Lifetime CA1299577C (fr) 1987-01-09 1987-01-09 Acides tetrahydrocarbazole-1-alcanoiques

Country Status (1)

Country Link
CA (1) CA1299577C (fr)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005033112A2 (fr) * 2003-10-02 2005-04-14 Cephalon, Inc. Derives d'indole substitues
EP1697322A1 (fr) * 2003-12-15 2006-09-06 Merck Frosst Canada Ltd. Derives de tetrahydrocarbazole et de cyclopentanoindole substitues
US7105560B1 (en) 1999-07-23 2006-09-12 The Regents Of The University Of California Use of etodolac in the treatment of multiple myeloma
US7151100B1 (en) 1999-07-23 2006-12-19 The Regents Of The University Of California Indole compounds useful for the treatment of cancer
US7189752B2 (en) 1999-07-23 2007-03-13 Carson Dennis A Use of etodolac for the treatment of chronic lymphocytic leukemia
US7211599B2 (en) 2002-09-19 2007-05-01 The Regents Of The University Of California Use of etodolac to treat hyperplasia
US7361680B2 (en) 1999-07-23 2008-04-22 The Regents Of The University Of California Indole compounds useful for the treatment of cancer

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7105560B1 (en) 1999-07-23 2006-09-12 The Regents Of The University Of California Use of etodolac in the treatment of multiple myeloma
US7361680B2 (en) 1999-07-23 2008-04-22 The Regents Of The University Of California Indole compounds useful for the treatment of cancer
US7189752B2 (en) 1999-07-23 2007-03-13 Carson Dennis A Use of etodolac for the treatment of chronic lymphocytic leukemia
US7151100B1 (en) 1999-07-23 2006-12-19 The Regents Of The University Of California Indole compounds useful for the treatment of cancer
US7211599B2 (en) 2002-09-19 2007-05-01 The Regents Of The University Of California Use of etodolac to treat hyperplasia
WO2005033113A3 (fr) * 2003-10-02 2005-06-30 Salmedix Inc Derives indoles
WO2005033112A2 (fr) * 2003-10-02 2005-04-14 Cephalon, Inc. Derives d'indole substitues
WO2005033112A3 (fr) * 2003-10-02 2005-06-09 Salmedix Inc Derives d'indole substitues
US7314886B2 (en) 2003-10-02 2008-01-01 Cephalon, Inc. Tetrahydropyrano-indole derivatives
WO2005033113A2 (fr) * 2003-10-02 2005-04-14 Cephalon, Inc Derives indoles
US7446122B2 (en) 2003-10-02 2008-11-04 Cephalon, Inc. Substituted indole derivatives
EP1697322A1 (fr) * 2003-12-15 2006-09-06 Merck Frosst Canada Ltd. Derives de tetrahydrocarbazole et de cyclopentanoindole substitues
EP1697322A4 (fr) * 2003-12-15 2007-12-26 Merck Frosst Canada Ltd Derives de tetrahydrocarbazole et de cyclopentanoindole substitues

Similar Documents

Publication Publication Date Title
US4808608A (en) Tetrahydrocarbazole 1-alkanoic acids, pharmaceutical compositions and use
AU592615B2 (en) Tetrahydrocarbazol-1-alkanoic acids
EP0275667B1 (fr) N-Benzyl-indoles hétérosubstitués en position 3
US5081145A (en) Indole-2-alkanoic acids compositions of and anti allergic use thereof
WO2002042269A1 (fr) Derives de 3-aroylindole et leur utilisation en tant qu'agonistes des recepteurs cb2
LU86406A1 (fr) Imidazoquinoleines antithrombogenes cardiotoniques
JPS6163653A (ja) インド−ル−２−アルカン酸類
CZ285476B6 (cs) Heterocyklické aromatické oxazolové sloučeniny, jejich oximové, ketonové, ketomethylenové, esterové a amidové sloučeniny a farmaceutické přípravky, inhibitory cyklooxygenasy a protizánětlivá činidla obsahující tyto oxazolové sloučeniny
JP2006510673A (ja) プラスミノゲンアクティベータインヒビター１（ｐａｉ−１）のインヒビターとしての、アリール、アリールオキシ、および、アルキルオキシ置換１ｈ−インドール−３−イルグリオキシル酸誘導体
JP2003501464A (ja) シクロオキシゲナーゼ−２の阻害剤としての１−（４−スルファミルアリール）−３−置換−５−アリール−２−ピラゾリン
EP0117462A2 (fr) N-(2-4-(1H-imidazol-1-yl)alkyl)arylamides
US4940719A (en) Tetrahydrocarbazole esters, pharmaceutical compositions and use
CA1299577C (fr) Acides tetrahydrocarbazole-1-alcanoiques
JPH0641095A (ja) 置換トリアゾロンおよびトリアゾールジオンの抗うつ性３−ハロフェニルピペラジニル−プロピル誘導体
US4775680A (en) Cyclohept[b]indolealkanoic acids, pharmaceutical compositions and use
CA2289573A1 (fr) N-triazolyl-2-indolecarboxamides et leur utilisation comme agonistes de cck-a
JP3465827B2 (ja) アザインドール誘導体およびこれを有効成分とする抗潰瘍薬
EP0239306B1 (fr) Esters de tétrahydrocarbazoles
CA1326030C (fr) Acides cyclohept[b]indole alcanoiques
US7250434B2 (en) CCK-1 receptor modulators
HU187634B (en) Process for producing alkanolamine derivatives
CA1305485C (fr) Acides tetrahydrocarbazole-1-alcanoiques
US4906654A (en) Cyclohept[b]indoleakanoic acids, pharmaceutical compositions and use
CA1330090C (fr) Esters de type tetrahydrocarbazole
BE1009376A4 (fr) Derives du carboxymethylidenecycloheptimidazole, procede de preparation de ces derniers et agents therapeutiques contenant ces composes.

Legal Events

Date Code Title Description
MKLA Lapsed